TNT study shows Lipitor 80mg reduces cardiovascular events in heart patients
Friday, September 05, 2008 13:00 IST New York
Pfizer announced that in patients with established heart disease, Lipitor (atorvastatin calcium) 80 mg not only significantly reduced the relative risk of suffering a first cardiovascular event by 19 per cent